| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 14.856 | 32.090 | 20.068 | 29.221 | 45.256 |
| Total Income - EUR | - | - | - | - | - | 14.856 | 32.384 | 20.068 | 29.221 | 45.256 |
| Total Expenses - EUR | - | - | - | - | - | 15.684 | 28.706 | 27.023 | 26.124 | 35.894 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -828 | 3.678 | -6.954 | 3.097 | 9.362 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.084 | 3.447 | -7.347 | 2.805 | 8.918 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Optilaser Vision Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.107 | 4.357 | 5.419 | 7.187 | 15.087 |
| Inventories | - | - | - | - | - | 91 | 1.473 | 1 | 3.217 | 6.498 |
| Receivables | - | - | - | - | - | 532 | 2.051 | 3.661 | 3.709 | 3.837 |
| Cash | - | - | - | - | - | 484 | 833 | 1.758 | 261 | 4.752 |
| Shareholders Funds | - | - | - | - | - | -1.043 | 2.428 | -4.912 | -2.141 | 6.789 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 0 | 0 |
| Debts | - | - | - | - | - | 2.157 | 2.966 | 14.515 | 12.069 | 9.930 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Optilaser Vision Med S.r.l.